Jubilant Pharmova Limited

JUBLPHARMA

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 202667

    Quarter₹ croreYoY
    Jun 2024167-23.3%
    Sept 2024166-11.1%
    Dec 2024196+11.9%
    Mar 2025217+5.6%
    Jun 202560-64.3%
    Sept 202566-59.9%
    Dec 202567-65.7%
    Mar 202670-67.6%
    Jun 202667+12.8%
  • ₹ crore

    Jun 20260.10

    Quarter₹ crore
    Jun 202420
    Sept 202444
    Dec 202418
    Mar 202518
    Jun 20250.70
    Sept 20250.80
    Dec 20250.40
    Mar 20260.50
    Jun 20260.10
  • ₹ crore

    Jun 202667

    Quarter₹ crore
    Jun 2024186
    Sept 2024210
    Dec 2024214
    Mar 2025235
    Jun 202560
    Sept 202567
    Dec 202568
    Mar 202671
    Jun 202667
  • Cost structure
  • ₹ crore

    Jun 202628

    Quarter₹ crore
    Jun 202449
    Sept 202451
    Dec 202452
    Mar 202551
    Jun 202523
    Sept 202527
    Dec 202529
    Mar 202625
    Jun 202628
  • ₹ crore

    Jun 202657

    Quarter₹ crore
    Jun 2024186
    Sept 2024193
    Dec 2024206
    Mar 2025212
    Jun 202554
    Sept 202559
    Dec 202558
    Mar 202658
    Jun 202657
  • Exceptional items and tax
  • ₹ crore

    Jun 202610

    Quarter₹ crore
    Jun 2024-11
    Sept 202417
    Dec 20249
    Mar 202524
    Jun 20257
    Sept 20259
    Dec 202510
    Mar 20264
    Jun 202610
  • ₹ crore

    Jun 20263

    Quarter₹ crore
    Jun 2024-1
    Sept 20246
    Dec 20243
    Mar 202510
    Jun 20252
    Sept 202557
    Dec 20254
    Mar 2026-53
    Jun 20263
  • Profit
  • ₹ crore

    Jun 20267

    Quarter₹ croreYoY
    Jun 2024-10-636.8%
    Sept 202411+2725.0%*
    Dec 20245+320.8%*
    Mar 202514-58.2%
    Jun 20256+156.9%*
    Sept 2025-6-161.0%
    Dec 20257+24.5%
    Mar 202657+320.6%
    Jun 20267+25.9%
  • Per share
  • ₹ per share

    Jun 20260.46

    Quarter₹ per share
    Jun 2024-0.64
    Sept 20240.66
    Dec 20240.33
    Mar 20250.86
    Jun 20250.36
    Sept 2025-0.40
    Dec 20250.42
    Mar 20263.59
    Jun 20260.46
  • Leverage
  • Debt to equity

    times

    Dec 20240.00x

    Quartertimes
    Jun 2024—
    Sept 20240.00x
    Dec 20240.00x
    Mar 2025—
    Jun 2025—
    Sept 2025—
    Dec 2025—
    Mar 2026—
    Jun 2026—
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
1671661962176066677067
Revenue YoY-23.3%-11.1%+11.9%+5.6%-64.3%-59.9%-65.7%-67.6%+12.8%
204418180.700.800.400.500.10
1862102142356067687167
Cost structure
495152512327292528
1861932062125459585857
Exceptional items and tax
-11179247910410
-163102574-533
Profit
-10115146-67577
Net profit YoY-636.8%+2725.0%*+320.8%*-58.2%+156.9%*-161.0%+24.5%+320.6%+25.9%
Per share
-0.640.660.330.860.36-0.400.423.590.46
Leverage
Debt to equity—0.00x0.00x——————

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.